Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor
Tumors are a serious threat to human health. The oncolytic virus is a kind of tumor killer virus which can infect and lyse cancer cells and spread through the tumor, while leaving normal cells largely unharmed. Mathematical models can help us to understand the tumor-virus dynamics and find better tr...
Main Authors: | Yongmei Su, Chen Jia, Ying Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2016/5621313 |
Similar Items
-
Triple threat to cancer: rationale for combining oncolytic viruses, MEK inhibitors, and immune checkpoint blockade
by: Praveen K. Bommareddy, et al.
Published: (2019-04-01) -
Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus with MEK Inhibitor Trametinib in Some BRAF or KRAS-Mutated Colorectal or Lung Carcinoma Models
by: XuSha Zhou, et al.
Published: (2021-09-01) -
Tumor Restrictions to Oncolytic Virus
by: Markus Vähä-Koskela, et al.
Published: (2014-04-01) -
Cyclical Treatment of Colorectal Tumor Spheroids Induces Resistance to MEK Inhibitors
by: Pradip Shahi Thakuri, et al.
Published: (2019-03-01) -
Oncolytic Viruses as a Platform for the Treatment of Malignant Brain Tumors
by: Jana de Sostoa, et al.
Published: (2020-10-01)